Schering Vanceril DS press release and visual aid claims cited in FDA ad division letter.
Executive Summary
SCHERING VANCERIL DS SUPERIORITY CLAIMS TO VANCERIL CITED BY FDA in a Jan. 24 letter from the Division of Drug Marketing, Advertising & Communications. DDMAC objected to a visual aid and press release for Vanceril DS 84 mcg inhalation aerosol (beclomethasone dipropionate). Schering-Plough launched Vanceril DS in January ("The Pink Sheet" Jan. 6, In Brief).